Camphor, lidocaine, and methyl salicylate topical and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Camphor, lidocaine, and methyl salicylate topical and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: camphor / lidocaine / methyl salicylate topical
Brand name: JointFlex, Original Ointment, Viva
Synonyms: Camphor, lidocaine, and methyl salicylate (topical)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camphor, lidocaine, and methyl salicylate topical-Insulin glargine, recombinant Subcutaneous
- Camphor, lidocaine, and methyl salicylate topical-Insulin glulisine
- Camphor, lidocaine, and methyl salicylate topical-Insulin Glulisine (Cartridges and Pens)
- Camphor, lidocaine, and methyl salicylate topical-Insulin Glulisine (Vials)
- Camphor, lidocaine, and methyl salicylate topical-Insulin glulisine Subcutaneous
- Camphor, lidocaine, and methyl salicylate topical-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Camptosar
- Insulin glargine and lixisenatide Subcutaneous-Camrese
- Insulin glargine and lixisenatide Subcutaneous-Camrese extended-cycle
- Insulin glargine and lixisenatide Subcutaneous-Camrese Lo
- Insulin glargine and lixisenatide Subcutaneous-Camrese Lo extended-cycle
- Insulin glargine and lixisenatide Subcutaneous-Canagliflozin